surmount-1 tirzepatide non-diabetic weight loss SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, Lilly Shows Tirzepatide Superiority in

Fitness influencers, travel creators, beach lifestyle content and beauty-focused accounts all contributed to a growing interest in achieving and maintaining a bronzed complexion

How to combat it: Rotate injection sites to prevent irritation

Karkossa I, Bannuscher A, Hellack B, Wohlleben W, Laloy J, Stan MS, Dinischiotu A, Wiemann M, Luch A, Haase A, et al

When those answers arrive, they may reshape how we think about both metabolic and neurological health

Which are the late-stage emerging therapies under development for the treatment of approved and potential indications

Retatrutide's approximately 6-day half-life directly supports a once-weekly subcutaneous injection regimen, maintaining relatively stable plasma drug levels between doses and mirroring the dosing schedules of other long-acting incretin-based therapies such as semaglutide and tirzepatide